BOSTON OMAHA CORP-CL A (BOC) Fundamental Analysis & Valuation

NYSE:BOC • US1010441053

Current stock price

12.13 USD
+0.08 (+0.66%)
At close:
12.37 USD
+0.24 (+1.98%)
Pre-Market:

This BOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BOC Profitability Analysis

1.1 Basic Checks

  • BOC had negative earnings in the past year.
  • In the past year BOC had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BOC reported negative net income in multiple years.
  • Of the past 5 years BOC 4 years had a positive operating cash flow.
BOC Yearly Net Income VS EBIT VS OCF VS FCFBOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.03%, BOC is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
  • With a decent Return On Equity value of -0.04%, BOC is doing good in the industry, outperforming 70.65% of the companies in the same industry.
Industry RankSector Rank
ROA -0.03%
ROE -0.04%
ROIC N/A
ROA(3y)-0.02%
ROA(5y)1.3%
ROE(3y)-0.04%
ROE(5y)2.1%
ROIC(3y)N/A
ROIC(5y)N/A
BOC Yearly ROA, ROE, ROICBOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • BOC has a Gross Margin of 67.24%. This is amongst the best in the industry. BOC outperforms 84.78% of its industry peers.
  • In the last couple of years the Gross Margin of BOC has declined.
  • BOC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y-1.7%
BOC Yearly Profit, Operating, Gross MarginsBOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BOC Health Analysis

2.1 Basic Checks

  • BOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BOC has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BOC has been increased compared to 5 years ago.
  • The debt/assets ratio for BOC is higher compared to a year ago.
BOC Yearly Shares OutstandingBOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BOC Yearly Total Debt VS Total AssetsBOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BOC has an Altman-Z score of 1.42. This is a bad value and indicates that BOC is not financially healthy and even has some risk of bankruptcy.
  • BOC's Altman-Z score of 1.42 is fine compared to the rest of the industry. BOC outperforms 65.22% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that BOC is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.08, BOC is doing good in the industry, outperforming 72.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACCN/A
WACC8.53%
BOC Yearly LT Debt VS Equity VS FCFBOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • BOC has a Current Ratio of 2.07. This indicates that BOC is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of BOC (2.07) is better than 73.91% of its industry peers.
  • BOC has a Quick Ratio of 2.07. This indicates that BOC is financially healthy and has no problem in meeting its short term obligations.
  • BOC's Quick ratio of 2.07 is fine compared to the rest of the industry. BOC outperforms 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07
BOC Yearly Current Assets VS Current LiabilitesBOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BOC Growth Analysis

3.1 Past

  • BOC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
  • Looking at the last year, BOC shows a small growth in Revenue. The Revenue has grown by 6.92% in the last year.
  • The Revenue has been growing by 21.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y23.87%
Revenue growth 5Y21.21%
Sales Q2Q%3.73%

3.2 Future

  • BOC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -42.13% yearly.
  • BOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.54% yearly.
EPS Next Y-430.25%
EPS Next 2Y-42.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BOC Yearly Revenue VS EstimatesBOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BOC Yearly EPS VS EstimatesBOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. BOC Valuation Analysis

4.1 Price/Earnings Ratio

  • BOC is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BOC Price Earnings VS Forward Price EarningsBOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.77
BOC Per share dataBOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • BOC's earnings are expected to decrease with -42.13% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.13%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BOC Dividend Analysis

5.1 Amount

  • No dividends for BOC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BOC Fundamentals: All Metrics, Ratios and Statistics

BOSTON OMAHA CORP-CL A

NYSE:BOC (3/26/2026, 8:07:00 PM)

Premarket: 12.37 +0.24 (+1.98%)

12.13

+0.08 (+0.66%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners65.07%
Inst Owner ChangeN/A
Ins Owners3.99%
Ins Owner Change0.82%
Market Cap381.49M
Revenue(TTM)112.60M
Net Income(TTM)-231.30K
Analysts45
Price Target14.28 (17.72%)
Short Float %5.1%
Short Ratio10.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-273.93%
Min EPS beat(2)-331.02%
Max EPS beat(2)-216.83%
EPS beat(4)1
Avg EPS beat(4)23.93%
Min EPS beat(4)-331.02%
Max EPS beat(4)941.58%
EPS beat(8)1
Avg EPS beat(8)-103.94%
EPS beat(12)3
Avg EPS beat(12)320.2%
EPS beat(16)3
Avg EPS beat(16)-316.28%
Revenue beat(2)0
Avg Revenue beat(2)-3.2%
Min Revenue beat(2)-5.02%
Max Revenue beat(2)-1.39%
Revenue beat(4)2
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)1.31%
Revenue beat(8)4
Avg Revenue beat(8)-0.6%
Revenue beat(12)7
Avg Revenue beat(12)0.23%
Revenue beat(16)9
Avg Revenue beat(16)0.79%
PT rev (1m)0%
PT rev (3m)-17.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.39
P/FCF N/A
P/OCF 17.92
P/B 0.72
P/tB 1.3
EV/EBITDA 12.77
EPS(TTM)0
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)0.68
OCFY5.58%
SpS3.58
BVpS16.8
TBVpS9.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.03%
ROE -0.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.24%
FCFM N/A
ROA(3y)-0.02%
ROA(5y)1.3%
ROE(3y)-0.04%
ROE(5y)2.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y-1.7%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 2.01
Cap/Depr 108.95%
Cap/Sales 24.67%
Interest Coverage N/A
Cash Conversion 95.49%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z 1.42
F-Score4
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)225.08%
Cap/Depr(5y)197.89%
Cap/Sales(3y)44.31%
Cap/Sales(5y)37.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y-430.25%
EPS Next 2Y-42.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.92%
Revenue growth 3Y23.87%
Revenue growth 5Y21.21%
Sales Q2Q%3.73%
Revenue Next Year5.05%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y65.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year401.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.88%
OCF growth 3Y39.83%
OCF growth 5Y17.19%

BOSTON OMAHA CORP-CL A / BOC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BOSTON OMAHA CORP-CL A (BOC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BOC.


What is the valuation status for BOC stock?

ChartMill assigns a valuation rating of 0 / 10 to BOSTON OMAHA CORP-CL A (BOC). This can be considered as Overvalued.


What is the profitability of BOC stock?

BOSTON OMAHA CORP-CL A (BOC) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for BOC stock?

The Earnings per Share (EPS) of BOSTON OMAHA CORP-CL A (BOC) is expected to decline by -430.25% in the next year.